Skip to content
The Policy VaultThe Policy Vault

Pomalyst (pomalidomide capsules)Cigna

Systemic Light Chain Amyloidosis

Initial criteria

  • Patient age ≥ 18 years
  • Medication is used in combination with dexamethasone
  • Patient has tried at least one other regimen

Approval duration

1 year